| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daria Mochly-Rosen | Q56073232 |
| P2093 | author name string | Wei Zhou | |
| Hong Chai | |||
| Jerry Tsao | |||
| Richard Qinxue Ding | |||
| P2860 | cites work | Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets | Q24300809 |
| Direct Demonstration of Involvement of Protein Kinase Cα in the Ca2+-induced Platelet Aggregation | Q24300892 | ||
| PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation | Q24301041 | ||
| Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure | Q28276546 | ||
| Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway | Q28361224 | ||
| PKCalpha regulates platelet granule secretion and thrombus formation in mice | Q28505136 | ||
| Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells | Q28572253 | ||
| Essential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injury | Q28579623 | ||
| PKCtheta is required for hemostasis and positive regulation of thrombin-induced platelet aggregation and alpha-granule secretion | Q28586641 | ||
| A small molecule-kinase interaction map for clinical kinase inhibitors | Q29617451 | ||
| Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation | Q30442189 | ||
| Genetic analysis of the role of protein kinase Ctheta in platelet function and thrombus formation | Q33371697 | ||
| Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. | Q33944297 | ||
| Protein kinase C activation and its pharmacological inhibition in vascular disease | Q34097328 | ||
| Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta | Q34662000 | ||
| Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an athero-susceptible region of porcine aorta | Q34670556 | ||
| Vascular restenosis. Basic science and clinical implications | Q34676789 | ||
| Inflammation and restenosis in the stent era. | Q34993928 | ||
| Coated stents for the prevention of restenosis: Part I. | Q35001575 | ||
| Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. | Q46580801 | ||
| Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells | Q46740822 | ||
| Mechanical stress-activated PKCdelta regulates smooth muscle cell migration | Q47643239 | ||
| Protein kinase C isoforms in human aortic smooth muscle cells | Q47994379 | ||
| Integrin cleavage regulates bidirectional signalling in vascular smooth muscle cells | Q50275288 | ||
| Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. | Q50511731 | ||
| Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. | Q50647596 | ||
| The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2. | Q52101085 | ||
| Protein kinase C delta activated adhesion regulates vascular smooth muscle cell migration. | Q53546084 | ||
| Protein kinase C-alpha regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells | Q71083580 | ||
| Correlation between human vascular smooth muscle cell proliferation and protein kinase C alpha-expression: effect of d-alpha-tocopherol | Q71847485 | ||
| Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells | Q72591900 | ||
| Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model | Q72726591 | ||
| Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition | Q72897832 | ||
| Down-regulation of protein kinase C inhibits insulin-like growth factor I-induced vascular smooth muscle cell proliferation, migration, and gene expression | Q73025289 | ||
| Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells | Q73076597 | ||
| Activation of PKC-epsilon and ERK1/2 participates in shear-induced endothelial MCP-1 expression that is repressed by nitric oxide | Q73294016 | ||
| Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial | Q73558460 | ||
| Acute glucose-induced downregulation of PKC-betaII accelerates cultured VSMC proliferation | Q74172709 | ||
| Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation | Q77933845 | ||
| Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators | Q78162518 | ||
| Systemic immunosuppressive therapy with oral Sirolimus after bare metal stent implantation: the missing alternative in the prevention of coronary restenosis after percutaneous coronary interventions | Q79809363 | ||
| Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts | Q80557758 | ||
| Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators | Q81708841 | ||
| Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities | Q83963995 | ||
| Coated stents for the prevention of restenosis: Part II. | Q35009006 | ||
| Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. | Q35691430 | ||
| In stent restenosis: bane of the stent era. | Q35769824 | ||
| Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis | Q35917050 | ||
| Vascular restenosis - striving for therapy | Q35925488 | ||
| Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice | Q36168899 | ||
| Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells | Q36711111 | ||
| PKC isozymes in chronic cardiac disease: possible therapeutic targets? | Q36962140 | ||
| Approaches for prevention of restenosis | Q37039843 | ||
| Preventing restenosis after angioplasty: a multistage approach | Q37056663 | ||
| Impaired activation of platelets lacking protein kinase C-theta isoform | Q37129685 | ||
| VCAM-1 signals activate endothelial cell protein kinase Calpha via oxidation | Q37263935 | ||
| Protein kinase C[delta] differentially regulates platelet functional responses | Q37344199 | ||
| Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. | Q37651042 | ||
| Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. | Q38289439 | ||
| Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation | Q38342165 | ||
| Calcineurin-NFAT signaling is involved in phenylephrine-induced vascular smooth muscle cell proliferation | Q39019415 | ||
| Activation of PKCbeta(II) and PKCtheta is essential for LDL-induced cell proliferation of human aortic smooth muscle cells via Gi-mediated Erk1/2 activation and Egr-1 upregulation. | Q40022023 | ||
| PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells | Q40411223 | ||
| The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. | Q40449899 | ||
| Regulation of expression of the endothelial cell nitric oxide synthase | Q41230965 | ||
| Spheciosterol sulfates, PKCzeta inhibitors from a philippine sponge Spheciospongia sp. | Q41327849 | ||
| Expression of six protein kinase C isotypes in endothelial cells | Q41502748 | ||
| Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. | Q41789528 | ||
| Acute stent thrombosis in a sirolimus eluting stent after wasp sting causing acute myocardial infarction: a case report | Q42152547 | ||
| The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production | Q42491396 | ||
| Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity | Q43611292 | ||
| Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. | Q43626701 | ||
| Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells | Q43660489 | ||
| Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation | Q43675828 | ||
| Identification of protein kinase Calpha as an essential, but not sufficient, cytosolic factor for Ca2+-induced alpha- and dense-core granule secretion in platelets | Q43701621 | ||
| Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation | Q43810240 | ||
| Overexpression of protein kinase C alpha and beta1 has distinct effects on bovine aortic endothelial cell growth | Q43881127 | ||
| High glucose abolishes the antiproliferative effect of 17beta-estradiol in human vascular smooth muscle cells | Q43908119 | ||
| Effects of hypoxia on rat airway smooth muscle cell proliferation | Q44355304 | ||
| Tumor Necrosis Factor-α Induces Early-Onset Endothelial Adhesivity by Protein Kinase Cζ–Dependent Activation of Intercellular Adhesion Molecule-1 | Q44417182 | ||
| Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells | Q44947018 | ||
| Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta | Q45042440 | ||
| Functional interaction of protein kinase Calpha with the tyrosine kinases Syk and Src in human platelets. | Q45176611 | ||
| Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII. | Q45182851 | ||
| Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. | Q45232098 | ||
| PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle | Q45241916 | ||
| Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation | Q45274653 | ||
| Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis | Q46277544 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 160-167 | |
| P577 | publication date | 2010-12-23 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology and Therapeutics | Q1855644 |
| P1476 | title | Therapeutic potential for protein kinase C inhibitor in vascular restenosis | |
| P478 | volume | 16 |
| Q39045977 | Antileukemic effects of midostaurin in acute myeloid leukemia - the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells |
| Q33833050 | Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease |
| Q36064282 | Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation. |
| Q54321998 | Dexmedetomidine-induced contraction involves c-Jun NH2 -terminal kinase phosphorylation through activation of the 5-lipoxygenase pathway in the isolated endothelium-denuded rat aorta. |
| Q49923465 | Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease |
| Q89841062 | IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium |
| Q64108192 | Mass Spectrometric Imaging Reveals Temporal and Spatial Dynamics of Bioactive Lipids in Arteries Undergoing Restenosis |
| Q90431751 | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension |
| Q41633518 | PKCε mediates resistin-induced NADPH oxidase activation and inflammation leading to smooth muscle cell dysfunction and intimal hyperplasia |
| Q47131231 | Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders |
| Q37695308 | Protein kinase C delta modulates endothelial nitric oxide synthase after cardiac arrest |
| Q37141320 | Protein kinase C, an elusive therapeutic target? |
| Q38001437 | Restenosis and therapy |
| Q35559964 | TNF-α mediates PKCδ/JNK1/2/c-Jun-dependent monocyte adhesion via ICAM-1 induction in human retinal pigment epithelial cells |
Search more.